Agilent provides xCELLigence impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers.
Discover
Related topics
Intoducing cellenONE: The revolutionary Single Cell isolator
May 25, 2022
A revolutionary platform based on sciDROP PICO precision dispensing technology and coupled with advanced image...
May 4, 2022
A prodigy incorporating a unique combination of patent-pending innovative technologies that takes flow cytometry to the...
Introducing Celloger Mini Plus: Automated and compact Live cell imaging inside your incubator
Apr 11, 2022
We are happy to introduce new Celloger Mini Plus, automated live cell imaging system! Click the video below to find out...
CQ1 live-cell confocal system: revealing the pathophysiology of COVID-19 infection
Mar 21, 2022
Yokogawa decided to support the world’s fight against COVID-19, scientifically cooperating with research facilities...
Introducing IsoPlexis Single-Cell Natural Killer Panel
Mar 4, 2022
Because of their ability to kill tumour cells, NK cells are an attractive target in cancer immunotherapy, therapeutic...
Enhanced small particle detection on CytekAurora and Northern Lights
Mar 2, 2022
Aurora system with ESP option, can fully resolve particles around 70nm and from the 80nm PS bead. The new violet laser...
Aurora CS spectral sorter - 28 Color in-depth purity sorting
Jan 28, 2022
To demonstrate the Cytek Aurora CS’s capabilities made possible by its advanced electronics design, a 28-color human...
Download today your IsoPlexis e-book: understanding immune Cell Function In Cancer
Dec 1, 2021
Understanding complex immune-cancer interactions is critical to identifying therapeutic targets, devising novel avenues...
IsoPlexis technology: accelerating decisions in immunotherapy with predictive single-cell response
Nov 26, 2021
The IsoLight is a hub for comprehensive functional profiling of each cell type across a large assay menu of single-cell...
Customer Story: Automation at DKMS LIFE SCIENCE LAB
Nov 25, 2021
How DKMS LIFE SCIENCE LAB is Supporting the Fight against Leukemia with New Processes and Automation
Mar 3, 2016
Many in vitro assays have been developed to screen and evaluate the efficacy of immune cell-mediated killing. The most common of these is the release assay where effector cell-mediated disruption of the target cell membrane results in leakage of its cytoplasmic contents into the culture medium. Endogenous biomolecules (such as lactate dehydrogenase) or previously added exogenous labels (such as the radioisotopes 51Cr or 111In) that leak into the media are then measured as an indirect readout of the damage caused by effector cells.
Alternative endpoint methods include flow cytometry, ELISA-based granzyme measurement, and morphometric analyses by microscopy. Although traditional end-point assays still serve as important tools for evaluating the efficacy of immune cell-mediated killing, there is a critical need for more efficient, homogeneous, automated assays (requiring less hands-on time) that aren’t hampered by the artifacts and hassle of using labels and that can provide quantitative results.
ACEA’s xCELLigence Real-Time Cell Analysis (RTCA) instruments utilize gold microelectrodes embedded in the bottom of microtiter wells to non-invasively monitor cell status including cell number, shape/size and attachment. The major distinguishing features of this technology include enhanced sensitivity, the preclusion of labels and, importantly, kinetic measurement of cell health/behavior.
Brand profile
Agilent provides xCELLigence impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers.
More info at:
www.aceabio.com